{
    "medicine_id": "7ededd7766d307c4cacc44374dc9a1da76c2fbce",
    "platform_id": "DB01271",
    "metadata": {
        "name": "Elaprase 6 mg 3mL Solution concentrate",
        "composition": "6 mg 3mL Idursulfase",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of Hunter syndrome in adults and children ages 5 and older",
            "contraindications": {
                "disease": "There is no experience with overdosage of Idursulfase in humans Single intravenous doses of idursulfase up to 20 mg kg were not lethal in male rats and cynomolgus monkeys approximately 6 5 and 13 times respectively of the recommended human dose based on body surface area and there were no clinical signs of toxicity",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Idursulfase is a purified form of the lysosomal enzyme human iduronate 2 sulfatase of recombinant DNA origin It is designed to replace the natural enzyme increasing catabolism of certain accumulated glycosaminoglycans GAG which abnormally accumulate in multiple tissue types in patients with mucopolysaccharidosis II MPS II or Hunter syndrome",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}